Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00670Dihydrocodeine--
BADD_D00671Dihydroergotamine--
BADD_D00673Dihydrogen phosphate--
BADD_D00674Diltiazem--
BADD_D00675Diltiazem hydrochloride--
BADD_D00680Dimethyl fumarate0.124023%
BADD_D00685Dinutuximab--
BADD_D00686Diphenhydramine0.011014%
BADD_D00687Diphenhydramine hydrochloride--
BADD_D00688Diphenoxylate hydrochloride--
BADD_D00692Dipyridamole--
BADD_D00693Disopyramide--
BADD_D00702Dolasetron--
BADD_D00703Dolasetron mesylate--
BADD_D00705Domperidone--
BADD_D00706Donepezil--
BADD_D00707Donepezil hydrochloride--
BADD_D00711Dornase alfa--
BADD_D00712Dorzolamide--
BADD_D00713Dorzolamide hydrochloride--
BADD_D00714Dothiepin hydrochloride--
BADD_D00715Doxacurium chloride--
BADD_D00718Doxazosin0.000722%
BADD_D00719Doxazosin mesylate--
BADD_D00720Doxepin--
BADD_D00722Doxercalciferol0.057354%
BADD_D00723Doxorubicin--
BADD_D00725Doxycycline0.000151%
BADD_D00726Doxycycline calcium--
BADD_D00727Doxycycline hyclate--
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target